Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05286307 · ClinicalTrials.gov registry record · Phase 4
Adductor Canal Block and IPACK Block vs. Isolated Adductor Canal Block for Post-Operative Analgesia Following ACL Reconstruction With Bone Patellar Tendon Bone Autograft:
A Phase 4 study, sponsored by NYU Langone Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 102
- Enrollment target
NCT05286307 is a Phase 4 study that has completed, run by NYU Langone Health. The registered enrollment target is 102 participants.
The verdict
NCT05286307, a Phase 4 study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 102 participants
- Enrollment target
Study Summary
A randomized, single-blind, single-center study measuring the effects of adductor canal block combined with IPACK infiltration compared to adductor canal block alone on post-operative pain and opioid consumption in patients undergoing ACL reconstruction with Bone Patellar Tendon Bone Autograft
Interventions
- DRUG IPACK block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2022-07-11 |
| Est. Completion | 2023-12-18 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05286307
The ClinicalTrials.gov registry entry for NCT05286307 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which IPACK block is the first listed.
NCT05286307 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05286307 about?
NCT05286307 is a clinical study titled "Adductor Canal Block and IPACK Block vs. Isolated Adductor Canal Block for Post-Operative Analgesia Following ACL Reconstruction With Bone Patellar Tendon Bone Autograft:". A randomized, single-blind, single-center study measuring the effects of adductor canal block combined with IPACK infiltration compared to adductor canal block alone on post-operative pain and opioid consumption in patients undergoing ACL reconstruction with Bone Patellar Tendon Bone Autograft
What is the current status of trial NCT05286307?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 102 participants. The study started on 2022-07-11. Estimated completion is 2023-12-18.
What interventions are being tested in trial NCT05286307?
The interventions under investigation include: IPACK block (DRUG).
Who is sponsoring clinical trial NCT05286307?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.